Neurosense Therapeutics Ltd(NRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NRSN Neurosense Therapeutics Ltd

盘前交易 12-23 08:24:14 EST

1.36

+0.08

+6.25%

盘前1.39

+0.03+2.21%

08:22 EST

最高1.42	最低1.22	成交量127.53万
今开1.22	昨收1.28	日振幅15.63%
总市值3,145万	流通市值1,845万	总股本2,313万
成交额168.69万	换手率9.40%	流通股本1,357万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NRSN","market":"US","secType":"STK","nameCN":"Neurosense Therapeutics Ltd","latestPrice":1.36,"timestamp":1734728400000,"preClose":1.28,"halted":0,"volume":1275279,"hourTrading":{"tag":"盘前","latestPrice":1.39,"preClose":1.36,"latestTime":"08:22 EST","volume":7902,"amount":10688.776214399999,"timestamp":1734960132044},"delay":0,"floatShares":13567500,"shares":23126000,"eps":-0.668876,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.08,"latestTime":"12-23 08:24:14 EST","open":1.22,"high":1.42,"low":1.22,"amount":1686926.053354,"amplitude":0.15625,"askPrice":1.39,"askSize":95,"bidPrice":1.3,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.668876,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"listingDate":1639026000000,"adjPreClose":1.36,"preHourTrading":{"tag":"盘前","latestPrice":1.39,"preClose":1.36,"latestTime":"08:22 EST","volume":7902,"amount":10688.776214399999,"timestamp":1734960132044},"postHourTrading":{"tag":"盘后","latestPrice":1.3799,"preClose":1.36,"latestTime":"19:58 EST","volume":11762,"amount":16028.5496,"timestamp":1734742710627},"volumeRatio":1.8052216825494833},"requestUrl":"/m/hq/s/NRSN/tweets","defaultTab":"tweets","newsList":[{"id":"2493842344","title":"Neurosense Therapeutics Ltd.盘中异动 急速上涨6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493842344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493842344?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:10","pubTimestamp":1734711011,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时10分，Neurosense Therapeutics Ltd.股票出现异动，股价急速上涨6.25%。截至发稿，该股报1.36美元/股，成交量56.75万股，换手率2.45%，振幅9.38%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.10%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221001011a1fe52ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221001011a1fe52ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"gpt_icon":0},{"id":"2492617141","title":"Neurosense Therapeutics Ltd.盘中异动 早盘股价大跌5.09%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492617141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492617141?lang=zh_cn&edition=full","pubTime":"2024-12-19 22:36","pubTimestamp":1734618987,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日22时36分，Neurosense Therapeutics Ltd.股票出现异动，股价大幅下跌5.09%。截至发稿，该股报1.08美元/股，成交量5.1328万股，换手率0.22%，振幅2.63%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为2.44%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223627ab84a004&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219223627ab84a004&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","BK4139","LENZ"],"gpt_icon":0},{"id":"1196225570","title":"NeuroSense Therapeutics九个月每股收益从去年同期的$(0.55)上涨至$(0.48)","url":"https://stock-news.laohu8.com/highlight/detail?id=1196225570","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196225570?lang=zh_cn&edition=full","pubTime":"2024-12-18 23:37","pubTimestamp":1734536236,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics(LENZ)九个月每股收益从去年同期的$(0.55)上涨至$(0.48)以上内容来自Benzinga Earnings专栏，原文如下：NeuroSense $Therapeutics(LENZ)$ 9-Month EPS $(0.48) Up From $(0.55) YoY","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","LENZ"],"gpt_icon":0},{"id":"2492184457","title":"Neurosense Therapeutics Ltd.盘中异动 早盘大幅拉升5.32%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492184457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492184457?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:42","pubTimestamp":1734532927,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时42分，Neurosense Therapeutics Ltd.股票出现波动，股价急速上涨5.32%。截至发稿，该股报1.15美元/股，成交量15.1527万股，换手率0.66%，振幅8.26%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.05%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121822420795ea54fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121822420795ea54fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","LENZ","BK4139"],"gpt_icon":0},{"id":"2492966092","title":"Neurosense Therapeutics Ltd.盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492966092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492966092?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:30","pubTimestamp":1734445847,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日22时30分，Neurosense Therapeutics Ltd.股票出现波动，股价大幅拉升5.24%。截至发稿，该股报0.930美元/股，成交量4425股，换手率0.02%，振幅0.00%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.00%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121722304795ea31eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121722304795ea31eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","LENZ","BK4139"],"gpt_icon":0},{"id":"2491102690","title":"Neurosense Therapeutics Ltd.盘中异动 早盘急速跳水5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491102690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491102690?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:57","pubTimestamp":1734361025,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时57分，Neurosense Therapeutics Ltd.股票出现异动，股价急速下跌5.38%。截至发稿，该股报0.814美元/股，成交量8.5415万股，换手率0.37%，振幅4.65%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.69%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216225705ab7ca0bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216225705ab7ca0bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","BK4139","LENZ"],"gpt_icon":0},{"id":"2491376668","title":"Neurosense Therapeutics Ltd.盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491376668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491376668?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:37","pubTimestamp":1734100653,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时37分，Neurosense Therapeutics Ltd.股票出现波动，股价快速下跌5.26%。截至发稿，该股报0.881美元/股，成交量1.7641万股，换手率0.09%，振幅4.05%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.07%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213223734984bd6f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213223734984bd6f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"gpt_icon":0},{"id":"2490868666","title":"Neurosense Therapeutics Ltd.盘中异动 急速下挫7.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490868666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490868666?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:30","pubTimestamp":1733927454,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时30分，Neurosense Therapeutics Ltd.股票出现异动，股价急速跳水7.00%。截至发稿，该股报0.949美元/股，成交量36.1412万股，换手率1.75%，振幅0.00%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.00%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121122305595e8f7e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121122305595e8f7e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NRSN"],"gpt_icon":0},{"id":"2490023405","title":"Neurosense Therapeutics Ltd.盘中异动 下午盘股价大跌5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490023405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490023405?lang=zh_cn&edition=full","pubTime":"2024-12-11 04:29","pubTimestamp":1733862562,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日04时29分，Neurosense Therapeutics Ltd.股票出现波动，股价大幅跳水5.88%。截至发稿，该股报0.960美元/股，成交量12.599万股，换手率0.61%，振幅4.90%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.73%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211042922ab6d8af7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211042922ab6d8af7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","LENZ","BK4139"],"gpt_icon":0},{"id":"2488190644","title":"Neurosense Therapeutics Ltd.盘中异动 早盘股价大跌5.31%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488190644","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488190644?lang=zh_cn&edition=full","pubTime":"2024-12-04 23:02","pubTimestamp":1733324529,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日23时02分，Neurosense Therapeutics Ltd.股票出现波动，股价急速跳水5.31%。截至发稿，该股报1.07美元/股，成交量7.0406万股，换手率0.34%，振幅5.75%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.04%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204230209971ba248&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204230209971ba248&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"gpt_icon":0},{"id":"2488946515","title":"Neurosense Therapeutics Ltd.盘中异动 早盘股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488946515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488946515?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:32","pubTimestamp":1733236326,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时32分，Neurosense Therapeutics Ltd.股票出现波动，股价快速跳水5.35%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.16%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223207a2699592&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223207a2699592&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"gpt_icon":0},{"id":"2488831677","title":"Neurosense Therapeutics Ltd.盘中异动 早盘股价大涨7.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488831677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488831677?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:31","pubTimestamp":1733149896,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时31分，Neurosense Therapeutics Ltd.股票出现异动，股价快速上涨7.13%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.03%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223136a266987e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223136a266987e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","BK4139","LENZ"],"gpt_icon":0},{"id":"2486038594","title":"Neurosense Therapeutics Ltd.盘中异动 大幅拉升5.56%报0.950美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486038594","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486038594?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:34","pubTimestamp":1732545266,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时34分，Neurosense Therapeutics Ltd.股票出现异动，股价快速拉升5.56%。截至发稿，该股报0.950美元/股，成交量2664股，换手率0.01%，振幅6.10%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为1.09%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223426abddfb85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223426abddfb85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NRSN"],"gpt_icon":0},{"id":"2485446466","title":"Neurosense Therapeutics Ltd.盘中异动 股价大跌8.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485446466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485446466?lang=zh_cn&edition=full","pubTime":"2024-11-22 02:35","pubTimestamp":1732214140,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日02时35分，Neurosense Therapeutics Ltd.股票出现波动，股价大幅下挫8.01%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.76%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112202354098e43fd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112202354098e43fd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"gpt_icon":0},{"id":"2484381110","title":"Neurosense Therapeutics Ltd.盘中异动 大幅跳水5.38%报1.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484381110","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484381110?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:47","pubTimestamp":1732114076,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时47分，Neurosense Therapeutics Ltd.股票出现异动，股价大幅跳水5.38%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.34%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120224757abd23a4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120224757abd23a4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"gpt_icon":0},{"id":"2484973746","title":"Neurosense Therapeutics Ltd.盘中异动 股价大跌5.93%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484973746","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484973746?lang=zh_cn&edition=full","pubTime":"2024-11-20 01:37","pubTimestamp":1732037878,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日01时37分，Neurosense Therapeutics Ltd.股票出现异动，股价快速跳水5.93%。截至发稿，该股报1.11美元/股，成交量9.1897万股，换手率0.46%，振幅4.24%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为1.10%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120013759abcfbb90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120013759abcfbb90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"gpt_icon":0},{"id":"2484602613","title":"Neurosense Therapeutics Ltd.盘中异动 下午盘急速下挫5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484602613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484602613?lang=zh_cn&edition=full","pubTime":"2024-11-19 02:29","pubTimestamp":1731954563,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日02时29分，Neurosense Therapeutics Ltd.股票出现波动，股价急速下跌5.69%。截至发稿，该股报1.16美元/股，成交量6.1616万股，换手率0.31%，振幅7.72%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.01%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119022925abcd115b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119022925abcd115b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NRSN","BK4139"],"gpt_icon":0},{"id":"2480987581","title":"Neurosense Therapeutics Ltd.盘中异动 股价大跌5.98%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480987581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480987581?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:37","pubTimestamp":1730731053,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时37分，Neurosense Therapeutics Ltd.股票出现异动，股价大幅下跌5.98%。截至发稿，该股报1.19美元/股，成交量4420股，换手率0.02%，振幅2.36%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为0.16%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223734a2154b85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223734a2154b85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","BK4139","LENZ"],"gpt_icon":0},{"id":"2480837244","title":"Neurosense Therapeutics Ltd.盘中异动 下午盘股价大涨5.60%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480837244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480837244?lang=zh_cn&edition=full","pubTime":"2024-11-02 01:23","pubTimestamp":1730481830,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日01时23分，Neurosense Therapeutics Ltd.股票出现异动，股价急速拉升5.60%。截至发稿，该股报1.32美元/股，成交量12.1286万股，换手率0.61%，振幅5.60%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体涨幅为0.57%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110201235098e40104&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110201235098e40104&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","NRSN"],"gpt_icon":0},{"id":"2479157034","title":"Neurosense Therapeutics Ltd.盘中异动 早盘急速下挫6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479157034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479157034?lang=zh_cn&edition=full","pubTime":"2024-10-31 23:00","pubTimestamp":1730386803,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日23时00分，Neurosense Therapeutics Ltd.股票出现波动，股价急速跳水6.92%。截至发稿，该股报1.21美元/股，成交量2.512万股，换手率0.13%，振幅6.15%。Neurosense Therapeutics Ltd.股票所在的生物技术行业中，整体跌幅为3.42%。Neurosense Therapeutics Ltd.公司简介：NeuroSense Therapeutics Ltd是一家临床阶段的生物技术公司，专注于发现和开发患有衰弱性神经退行性疾病的患者的治疗方法，这些疾病包括肌萎缩性侧索硬化症，阿尔茨海默病和帕金森病等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103123000398e3fc22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103123000398e3fc22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRSN","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurosense-tx.com","stockEarnings":[{"period":"1week","weight":0.5814},{"period":"1month","weight":0.3736},{"period":"3month","weight":0.0462},{"period":"6month","weight":0.5145},{"period":"1year","weight":0.7503},{"period":"ytd","weight":0.7325}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NeuroSense Therapeutics Ltd.于2017年2月13日在以色列注册成立。该公司是一家临床阶段的生物技术公司，专注于发现和开发针对神经退行性疾病患者的治疗方法，包括肌萎缩性侧索硬化症（ALS）、阿尔茨海默病（AD）和帕金森病（PD）。公司的主要候选治疗药物PrimeC是一种新型的缓释口服制剂，由两种FDA批准的药物环丙沙星和塞来昔布组成的固定剂量组合。PrimeC旨在通过调节microRNA合成、铁积累和神经炎症来治疗ALS，所有这些都是ALS病理的标志。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.221221},{"month":2,"riseRate":1,"avgChangeRate":0.311932},{"month":3,"riseRate":0.666667,"avgChangeRate":0.159968},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.220216},{"month":5,"riseRate":0,"avgChangeRate":-0.196146},{"month":6,"riseRate":0.666667,"avgChangeRate":0.463109},{"month":7,"riseRate":0,"avgChangeRate":-0.298623},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.020927},{"month":9,"riseRate":0.333333,"avgChangeRate":0.033411},{"month":10,"riseRate":0,"avgChangeRate":-0.15772},{"month":11,"riseRate":0.666667,"avgChangeRate":0.553258},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.098186}],"exchange":"NASDAQ","name":"Neurosense Therapeutics Ltd","nameEN":"Neurosense Therapeutics Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Neurosense Therapeutics Ltd(NRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Neurosense Therapeutics Ltd(NRSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Neurosense Therapeutics Ltd,NRSN,Neurosense Therapeutics Ltd股票,Neurosense Therapeutics Ltd股票老虎,Neurosense Therapeutics Ltd股票老虎国际,Neurosense Therapeutics Ltd行情,Neurosense Therapeutics Ltd股票行情,Neurosense Therapeutics Ltd股价,Neurosense Therapeutics Ltd股市,Neurosense Therapeutics Ltd股票价格,Neurosense Therapeutics Ltd股票交易,Neurosense Therapeutics Ltd股票购买,Neurosense Therapeutics Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Neurosense Therapeutics Ltd(NRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Neurosense Therapeutics Ltd(NRSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}